Jared Gollob
Publications by Year
Research Areas
Amyloidosis: Diagnosis, Treatment, Outcomes, RNA Interference and Gene Delivery, Immune Cell Function and Interaction, Cytokine Signaling Pathways and Interactions, Immunotherapy and Immune Responses
Most-Cited Works
- → Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis(2018)2,831 cited
- → Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis(2013)955 cited
- → Impairment of Mycobacterial Immunity in Human Interleukin-12 Receptor Deficiency(1998)840 cited
- → Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma(2004)815 cited
- → First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement(2013)692 cited
- → Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial(2013)571 cited
- → Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis(2019)458 cited
- → A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus(2010)435 cited
- → Role of Raf Kinase in Cancer: Therapeutic Potential of Targeting the Raf/MEK/ERK Signal Transduction Pathway(2006)355 cited
- → Safety, Pharmacokinetics, and Activity of ABX-EGF, a Fully Human Anti–Epidermal Growth Factor Receptor Monoclonal Antibody in Patients With Metastatic Renal Cell Cancer(2004)328 cited